CLINICAL_TRIALS
trial_result
· 2017-12-14
Clinical Trial Update: Use of Dapsone Gel, 5% for Treating Dermatitis Herpetiformis [Phase 4]
Summary
Phase 4 trial of dapsone gel 5% for dermatitis herpetiformis was terminated; results posted in 2017. No further details provided here.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vanderbilt University Medical Center | Conditions: Dermatitis Herpetiformis | Phase 4 | Status: TERMINATED | Results posted: 2017-12-14